BSE Ltd Share Price Today

Actions	Ex-Date	Record-Date
DividendsFinal Dividend of 500% at ₹10/Share	10-Jul-2026	10-Jul-2026
Bonus2:1	23-May-2025	23-May-2025
DividendsFinal Dividend of 900% at ₹18/Share	14-May-2025	14-May-2025
DividendsSpecial Dividend of 250% at ₹5/Share	14-May-2025	14-May-2025

Mutual Fund Holder	Aug 26 Shares held	Sep 26 Shares held
SBI Nifty 50 ETF	-	79.25 Lac (100%)
Nippon India Growth Mid Cap Fund - Growth Option	39.00 Lac	39.00 Lac no change
Kotak Flexi Cap Fund - Growth	31.00 Lac	31.00 Lac no change
UTI Nifty 50 ETF	-	27.18 Lac (100%)
Nippon India ETF Nifty 50 BeES	-	25.44 Lac (100%)

Vineet Chawla

31 Oct • 8:41 AM · SEBI-Registered Analyst

Bharat Electronics - Quaterly Results FY 2026

BEL

Bharat Electronics reported a strong September 2026 quarter. Sales rose 26.50% to Rs. 72,908.70 million, up from Rs. 57,636.50 million in the same quarter last year. Net profit grew 19.80% to Rs. 15,407.30 million, compared with Rs. 12,861.30 million a year earlier. Operating profit also climbed sharply, reaching Rs. 22,299.10 million against Rs. 18,544.20 million in the year-ago period. Overall, the company posted healthy growth across revenue and profitability, with sales expanding faster than net profit. Disclaimer: Investments in securities market are subject to market risks. Read all related documents carefully before investing. Registration granted by SEBI and certification from NISM in no way guarantee the performance of the intermediary or provide any assurance of returns to investors. The above information is for educational and learning purpose. They analyst or his associates do not hold any shares of the company and have no financial interest in it. SEBI Registered Research Analyst: Vineet Ashwinikumar Chawla: INH000008190, BSE Enlistment No: 5433

Vineet Chawla

31 Oct • 5:30 AM · SEBI-Registered Analyst

Shree Renuka Sugars Q2 Loss Narrows to Rs 1,632 Mn

RENUKA

Shree Renuka Sugars reported a net loss of Rs 1,632 million for the quarter ended September 2026, narrowing from a loss of Rs 3,188 million in the same quarter last year. Net sales fell 25.56% year-on-year to Rs 17,787 million, down from Rs 23,895 million in September 2025. Despite the drop in revenue, the company’s operating profit margin improved to 442% from -1,173% a year earlier, indicating a significant improvement in operating performance. The lower loss was driven by this margin recovery, even as the top line contracted sharply. Investors will watch whether the company can sustain the margin gains and return to revenue growth in the coming quarters. Disclaimer: Investments in securities market are subject to market risks. Read all related documents carefully before investing. Registration granted by SEBI and certification from NISM in no way guarantee the performance of the intermediary or provide any assurance of returns to investors. The above information is for educational and learning purpose. They analyst or his associates do not hold any shares of the company and have no financial interest in it. SEBI Registered Research Analyst: Vineet Ashwinikumar Chawla: INH000008190, BSE Enlistment No: 5433

Anish Rai

30 Oct • 11:53 PM · SEBI-Registered Analyst

Reliance Industries Posts Strong Q2 FY27 Performance;

RELIANCE

ies Limited (RIL), headed by Mukesh Ambani, reported a robust financial performance for the July–September quarter of FY27, supported by stronger refining margins, higher energy realisations and steady momentum across its diversified businesses. Consolidated profit attributable to the company's owners increased 40.6% year-on-year to ₹25,548 crore, while revenue from operations advanced to ₹3,32,861 crore. 🔥 KEY FINANCIAL HIGHLIGHTS 🔹 Net Profit (PAT): Reported at ₹29,250 crore in Q2 FY27. 🔹 Profit Attributable to Owners: Climbed 40.6% to ₹25,548 crore against ₹18,165 crore in the year-ago quarter. 🔹 Revenue from Operations: Rose to ₹3,32,861 crore compared with approximately ₹2.59 lakh crore in Q2 FY26. 🔹 EBITDA: Expanded 23.9% year-on-year to ₹62,409 crore. 📊 OIL-TO-CHEMICALS (O2C) BUSINESS Reliance's O2C division delivered substantial improvement during the quarter, driven by favourable energy prices and better realisations across various downstream chemical products. 🔹 Segment Revenue: ₹2,31,601 crore, registering 44.2% annual growth. 🔹 Segment EBITDA: Increased 67.9% to ₹25,203 crore. 🔹 Business Development: Jio-bp continued strengthening its fuel retail network and expanding its electric vehicle charging infrastructure. ⛽ OIL AND GAS BUSINESS UPDATE The Oil and Gas division witnessed a marginal decline in revenue during the September quarter, reflecting operating challenges and higher government levies. 🔹 Segment Revenue: Approximately ₹6,020 crore. 🔹 Segment EBITDA: ₹4,901 crore, down 2% year-on-year. Higher government charges and softer revenue weighed on the segment's operating profitability. #RelianceIndustries #RIL #Q2Results #Q2FY27 #MukeshAmbani #O2C #Jio #JioBP #OilAndGas #EnergySector #StockMarketIndia #NSE #BSE Disclaimer: Investment in securities market are subject to market risks. Read all the related documents carefully before investing.

Capital Investo Research

30 Oct • 11:49 PM · SEBI-Registered Analyst

RELIANCE: Q2 FY27 Results Net Profit Jumps 41% to ₹25,548 Cr

RELIANCE

Industries Limited (RIL), led by Mukesh Ambani, delivered a strong financial performance in the September quarter of FY27, reporting record quarterly revenue growth. The company benefited from improved refining margins, higher energy prices and continued momentum in its telecom business. Consolidated net profit attributable to owners increased approximately 40.6% year-on-year to ₹25,548 crore, while revenue from operations climbed to ₹3,32,861 crore. 🔥 KEY FINANCIAL HIGHLIGHTS 🔹 Net Profit (PAT): ₹29,250 crore for Q2 FY27. 🔹 Profit Attributable to Owners: ₹25,548 crore, compared with ₹18,165 crore in the corresponding quarter last year. 🔹 Revenue from Operations: Increased to ₹3,32,861 crore from approximately ₹2.59 lakh crore a year ago. 🔹 EBITDA: Grew 23.9% year-on-year to ₹62,409 crore. 📊 OIL TO CHEMICALS (O2C) PERFORMANCE Reliance's Oil-to-Chemicals division recorded significant growth during the quarter, supported by favourable energy prices and improved realisations across several downstream chemical products. 🔹 Segment Revenue: ₹2,31,601 crore, up 44.2% year-on-year. 🔹 Segment EBITDA: ₹25,203 crore, registering growth of 67.9%. 🔹 Business Update: Jio-bp continued expanding its fuel retailing operations and electric vehicle charging network. ⛽ OIL AND GAS SEGMENT The Oil and Gas business experienced a slight moderation in quarterly revenue amid changing operating conditions. 🔹 Segment Revenue: Approximately ₹6,020 crore. 🔹 Segment EBITDA: ₹4,901 crore, declining 2% year-on-year. Higher government levies and comparatively lower revenue impacted the segment's operating performance. #RelianceIndustries #RIL #Q2Results #Q2FY27 #MukeshAmbani #O2C #Jio #JioBP #OilAndGas #EnergySector #StockMarketIndia #NSE #BSE Disclaimer: Investment in securities market are subject to market risks. Read all the related documents carefully before investing.

Vineet Chawla

30 Oct • 10:57 PM · SEBI-Registered Analyst

Sun Pharma Q2FY27: Standalone Profit Jumps 54%

SUNPHARMA

Sun Pharmaceutical Industries has announced its results for the second quarter ended September 30, 2026 (Q2FY27), with profit trends differing between its standalone and consolidated numbers. On a standalone basis, net profit jumped 54.42% to Rs 871.29 crore, compared with Rs 564.22 crore in the same quarter last year. Total income rose 34.67% to Rs 6,222.93 crore from Rs 4,620.90 crore a year earlier. On a consolidated basis, net profit declined 36.22% to Rs 1,988.53 crore from Rs 3,117.95 crore in the year-ago quarter. However, total income grew 11.83% to Rs 16,716.03 crore, up from Rs 14,948.23 crore in Q2FY26. Disclaimer: Investments in securities market are subject to market risks. Read all related documents carefully before investing. Registration granted by SEBI and certification from NISM in no way guarantee the performance of the intermediary or provide any assurance of returns to investors. The above information is for educational and learning purpose. They analyst or his associates do not hold any shares of the company and have no financial interest in it. SEBI Registered Research Analyst: Vineet Ashwinikumar Chawla: INH000008190, BSE Enlistment No: 5433

Anish Rai

30 Oct • 8:51 PM · SEBI-Registered Analyst

Market Closing: Sensex Add 308 Pts Nifty Settle Above 23,000

Indian stock markets finished higher for the second straight trading session on Friday, October 30. The benchmark indices extended their recovery, with the Nifty 50 holding above 23,000 and the Sensex gaining more than 300 points. However, losses across several sectors and broader market stocks restricted the overall upside. 🔥 KEY MARKET HIGHLIGHTS 🔹 Sensex: Rose 308.49 points (0.42%) to finish at 74,459.53. 🔹 Nifty 50: Gained 116.35 points (0.51%) to close at 23,053.10. 📊 SECTOR-WISE PERFORMANCE IT and pharmaceutical shares emerged as the key outperformers, whereas selling pressure was visible across multiple other sectors. 🔹 IT: Advanced approximately 2.5%. 🔹 Pharma: Registered a gain of around 1.7%. 🔻 Consumer Durables: Fell more than 1%. 🔻 Energy: Declined over 1%. 🔻 Media: Traded lower by more than 1%. 🔻 Auto, Nifty Bank, PSU Bank and FMCG: Each ended approximately 0.5% lower. 📉 BROADER MARKET TRENDS Midcap and smallcap stocks witnessed profit-booking and lagged behind the benchmark indices. 🔹 Nifty Midcap: Slipped 0.4%. 🔹 Nifty Smallcap: Lost 1.6%. 📈 MARKET PERSPECTIVE Benchmark indices continued their positive momentum, supported primarily by IT and pharmaceutical stocks. Nevertheless, weakness in midcap and smallcap segments suggests that buying participation remained selective. Going forward, investors should monitor sectoral trends, institutional fund flows and important technical support and resistance levels for fresh market cues. #ClosingBell #Sensex #Nifty50 #StockMarketToday #ITStocks #PharmaStocks #MidcapStocks #SmallcapStocks #IndianStockMarket #NSE #BSE Disclaimer: Investment in securities market are subject to market risks. Read all the related documents carefully before ***** Sensex Adds 308 pts, Nifty Settles above 23,000

BSE Ltd. Share Price

Overview

Market Data

Open Price

Prev. Close

Day Low

Day High

52 Week Low

52 Week High

Fundamentals

Quick Bite

Price To Earnings Ratio

Sector PE

PB Ratio

Sector PB

EPS

Dividend Yield

Today's Volume

5 Day Avg. Volume

PEG Ratio

Market Cap.

StockGro Trade views

Technical Analysis

Forecasts 🧭

Financials

Corporate Actions

Mutual Fund Ownership

About BSE Ltd. 👋

Expert Opinions

Frequently Asked Questions

What is the share price of BSE Ltd.?

What is the market cap of BSE Ltd.?

Should I buy BSE Ltd. stock now?

What is the 52 week high and low of BSE Ltd.?

Is the BSE Ltd. stock good to buy?

Is BSE Ltd. a good buy for the long term?

Is BSE Ltd. overvalued or undervalued?

What is the PE and PB ratio of BSE Ltd.?